-
1
-
-
80355147292
-
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
-
Diamond MS, Kinder M, Matsushita H et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J Exp Med 2011; 208: 1989-2003.
-
(2011)
J Exp Med
, vol.208
, pp. 1989-2003
-
-
Diamond, M.S.1
Kinder, M.2
Matsushita, H.3
-
2
-
-
80355136945
-
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
-
Fuertes MB, Kacha AK, Kline J et al. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells. J Exp Med 2011; 208: 2005-16.
-
(2011)
J Exp Med
, vol.208
, pp. 2005-2016
-
-
Fuertes, M.B.1
Kacha, A.K.2
Kline, J.3
-
3
-
-
17144417748
-
Dendritic cells as therapeutic vaccines against cancer
-
Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005; 5: 296-306.
-
(2005)
Nat Rev Immunol
, vol.5
, pp. 296-306
-
-
Banchereau, J.1
Palucka, A.K.2
-
4
-
-
82755189230
-
Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients
-
Alfaro C, Perez-Gracia JL, Suarez N et al. Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients. J Immunol 2011; 187: 6130-42.
-
(2011)
J Immunol
, vol.187
, pp. 6130-6142
-
-
Alfaro, C.1
Perez-Gracia, J.L.2
Suarez, N.3
-
5
-
-
80052439234
-
Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients
-
Lesterhuis WJ, de Vries IJ, Schreibelt G et al. Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients. Clin Cancer Res 2011; 17: 5725-35.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 5725-5735
-
-
Lesterhuis, W.J.1
de Vries, I.J.2
Schreibelt, G.3
-
6
-
-
79960900889
-
Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study
-
Bauer C, Dauer M, Saraj S et al. Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study. Cancer Immunol Immunother 2011; 60: 1097-107.
-
(2011)
Cancer Immunol Immunother
, vol.60
, pp. 1097-1107
-
-
Bauer, C.1
Dauer, M.2
Saraj, S.3
-
7
-
-
34447287858
-
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate
-
Vlodavsky I, Ilan N, Naggi A, Casu B. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des 2007; 13: 2057-73.
-
(2007)
Curr Pharm Des
, vol.13
, pp. 2057-2073
-
-
Vlodavsky, I.1
Ilan, N.2
Naggi, A.3
Casu, B.4
-
8
-
-
0034845578
-
Molecular properties and involvement of heparanase in cancer progression and normal development
-
Vlodavsky I, Goldshmidt O, Zcharia E et al. Molecular properties and involvement of heparanase in cancer progression and normal development. Biochimie 2001; 83: 831-9.
-
(2001)
Biochimie
, vol.83
, pp. 831-839
-
-
Vlodavsky, I.1
Goldshmidt, O.2
Zcharia, E.3
-
9
-
-
0035999158
-
Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development
-
Vlodavsky I, Goldshmidt O, Zcharia E et al. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol 2002; 12: 121-9.
-
(2002)
Semin Cancer Biol
, vol.12
, pp. 121-129
-
-
Vlodavsky, I.1
Goldshmidt, O.2
Zcharia, E.3
-
10
-
-
0037162555
-
Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis
-
Goldshmidt O, Zcharia E, Abramovitch R et al. Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc Natl Acad Sci U S A 2002; 99: 10031-6.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 10031-10036
-
-
Goldshmidt, O.1
Zcharia, E.2
Abramovitch, R.3
-
11
-
-
77956624954
-
Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis
-
Barash U, Cohen-Kaplan V, Dowek I et al. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis. FEBS J 2010; 277: 3890-903.
-
(2010)
FEBS J
, vol.277
, pp. 3890-3903
-
-
Barash, U.1
Cohen-Kaplan, V.2
Dowek, I.3
-
12
-
-
0025013701
-
Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis
-
Vlodavsky I, Korner G, Ishai-Michaeli R, Bashkin P, Bar-Shavit R, Fuks Z. Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev 1990; 9: 203-26.
-
(1990)
Cancer Metastasis Rev
, vol.9
, pp. 203-226
-
-
Vlodavsky, I.1
Korner, G.2
Ishai-Michaeli, R.3
Bashkin, P.4
Bar-Shavit, R.5
Fuks, Z.6
-
13
-
-
0032417923
-
Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis
-
Mishima T, Murata J, Toyoshima M et al. Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis. Clin Exp Metastasis 1998; 16: 541-50.
-
(1998)
Clin Exp Metastasis
, vol.16
, pp. 541-550
-
-
Mishima, T.1
Murata, J.2
Toyoshima, M.3
-
14
-
-
34548474880
-
Dendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T-cell responses against gastric tumor cells in vitro
-
Cai YG, Fang DC, Chen L et al. Dendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T-cell responses against gastric tumor cells in vitro. Tumour Biol 2007; 28: 238-46.
-
(2007)
Tumour Biol
, vol.28
, pp. 238-246
-
-
Cai, Y.G.1
Fang, D.C.2
Chen, L.3
-
15
-
-
50949120270
-
HLA-A2-restricted cytotoxic T lymphocyte epitopes from human heparanase as novel targets for broad-spectrum tumor immunotherapy
-
Chen T, Tang XD, Wan Y et al. HLA-A2-restricted cytotoxic T lymphocyte epitopes from human heparanase as novel targets for broad-spectrum tumor immunotherapy. Neoplasia 2008; 10: 977-86.
-
(2008)
Neoplasia
, vol.10
, pp. 977-986
-
-
Chen, T.1
Tang, X.D.2
Wan, Y.3
-
16
-
-
77953058454
-
Cytotoxic T lymphocyte epitopes from human heparanase can elicit a potent anti-tumor immune response in mice
-
Tang XD, Liang GP, Li C et al. Cytotoxic T lymphocyte epitopes from human heparanase can elicit a potent anti-tumor immune response in mice. Cancer Immunol Immunother 2010; 59: 1041-7.
-
(2010)
Cancer Immunol Immunother
, vol.59
, pp. 1041-1047
-
-
Tang, X.D.1
Liang, G.P.2
Li, C.3
-
17
-
-
40449100254
-
H-2Kb-restricted CTL epitopes from mouse heparanase elicit an antitumor immune response in vivo
-
Tang XD, Wan Y, Chen L et al. H-2Kb-restricted CTL epitopes from mouse heparanase elicit an antitumor immune response in vivo. Cancer Res 2008; 68: 1529-37.
-
(2008)
Cancer Res
, vol.68
, pp. 1529-1537
-
-
Tang, X.D.1
Wan, Y.2
Chen, L.3
-
18
-
-
64549092429
-
Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice
-
Chen L, Tang XD, Yu ST et al. Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice. J Pathol 2009; 217: 685-92.
-
(2009)
J Pathol
, vol.217
, pp. 685-692
-
-
Chen, L.1
Tang, X.D.2
Yu, S.T.3
-
19
-
-
80051496177
-
Multiple antigenic peptides of human heparanase elicit a much more potent immune response against tumors
-
Wang GZ, Tang XD, Lü MH et al. Multiple antigenic peptides of human heparanase elicit a much more potent immune response against tumors. Cancer Prev Res (Phila) 2011; 4: 1285-95.
-
(2011)
Cancer Prev Res (Phila)
, vol.4
, pp. 1285-1295
-
-
Wang, G.Z.1
Tang, X.D.2
Lü, M.H.3
-
20
-
-
0035500466
-
Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens
-
Schirle M, Weinschenk T, Stevanovic S. Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens. J Immunol Methods 2001; 257: 1-16.
-
(2001)
J Immunol Methods
, vol.257
, pp. 1-16
-
-
Schirle, M.1
Weinschenk, T.2
Stevanovic, S.3
-
21
-
-
33947588271
-
Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes
-
Sundar K, Boesen A, Coico R. Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes. Virology 2007; 360: 257-63.
-
(2007)
Virology
, vol.360
, pp. 257-263
-
-
Sundar, K.1
Boesen, A.2
Coico, R.3
-
22
-
-
0025232814
-
Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids
-
Fields GB, Noble RL. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res 1990; 35: 161-214.
-
(1990)
Int J Pept Protein Res
, vol.35
, pp. 161-214
-
-
Fields, G.B.1
Noble, R.L.2
-
23
-
-
0028285230
-
Proliferating dendritic cell progenitors in human blood
-
Romani N, Gruner S, Brang D et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994; 180: 83-93.
-
(1994)
J Exp Med
, vol.180
, pp. 83-93
-
-
Romani, N.1
Gruner, S.2
Brang, D.3
-
24
-
-
0029858032
-
Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors
-
Garrigan K, Moroni-Rawson P, McMurray C et al. Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors. Blood 1996; 88: 3508-12.
-
(1996)
Blood
, vol.88
, pp. 3508-3512
-
-
Garrigan, K.1
Moroni-Rawson, P.2
McMurray, C.3
-
25
-
-
34247637147
-
Heparanase: a target for drug discovery in cancer and inflammation
-
McKenzie EA. Heparanase: a target for drug discovery in cancer and inflammation. Br J Pharmacol 2007; 151: 1-14.
-
(2007)
Br J Pharmacol
, vol.151
, pp. 1-14
-
-
McKenzie, E.A.1
-
26
-
-
84861133191
-
Vaccines for melanoma and renal cell carcinoma
-
Kaufman HL. Vaccines for melanoma and renal cell carcinoma. Semin Oncol 2012; 39: 263-75.
-
(2012)
Semin Oncol
, vol.39
, pp. 263-275
-
-
Kaufman, H.L.1
-
27
-
-
77951554477
-
Patented cancer vaccines: the promising leads
-
Aurisicchio L, Ciliberto G. Patented cancer vaccines: the promising leads. Expert Opin Ther Pat 2010; 20: 647-60.
-
(2010)
Expert Opin Ther Pat
, vol.20
, pp. 647-660
-
-
Aurisicchio, L.1
Ciliberto, G.2
-
28
-
-
74049106976
-
Current developments with peptide-based human tumor vaccines
-
Khazaie K, Bonertz A, Beckhove P. Current developments with peptide-based human tumor vaccines. Curr Opin Oncol 2009; 21: 524-30.
-
(2009)
Curr Opin Oncol
, vol.21
, pp. 524-530
-
-
Khazaie, K.1
Bonertz, A.2
Beckhove, P.3
-
30
-
-
41149160918
-
Antigen-specific immunotherapy of cervical and ovarian cancer
-
Hung CF, Wu TC, Monie A, Roden R. Antigen-specific immunotherapy of cervical and ovarian cancer. Immunol Rev 2008; 222: 43-69.
-
(2008)
Immunol Rev
, vol.222
, pp. 43-69
-
-
Hung, C.F.1
Wu, T.C.2
Monie, A.3
Roden, R.4
-
32
-
-
0141960452
-
Natural T cell immunity against cancer
-
Nagorsen D, Scheibenbogen C, Marincola FM, Letsch A, Keilholz U. Natural T cell immunity against cancer. Clin Cancer Res 2003; 9: 4296-303.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 4296-4303
-
-
Nagorsen, D.1
Scheibenbogen, C.2
Marincola, F.M.3
Letsch, A.4
Keilholz, U.5
-
33
-
-
33646755569
-
Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity
-
Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 2006; 90: 1-50.
-
(2006)
Adv Immunol
, vol.90
, pp. 1-50
-
-
Smyth, M.J.1
Dunn, G.P.2
Schreiber, R.D.3
-
34
-
-
4444243096
-
Tumor-specific shared antigenic peptides recognized by human T cells
-
Van Der Bruggen P, Zhang Y, Chaux P et al. Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev 2002; 188: 51-64.
-
(2002)
Immunol Rev
, vol.188
, pp. 51-64
-
-
Van Der Bruggen, P.1
Zhang, Y.2
Chaux, P.3
-
35
-
-
70449360735
-
Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma
-
Bonertz A, Weitz J, Pietsch DH et al. Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma. J Clin Invest 2009; 119: 3311-21.
-
(2009)
J Clin Invest
, vol.119
, pp. 3311-3321
-
-
Bonertz, A.1
Weitz, J.2
Pietsch, D.H.3
-
36
-
-
23144464171
-
Cancer/testis antigens, gametogenesis and cancer
-
Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005; 5: 615-25.
-
(2005)
Nat Rev Cancer
, vol.5
, pp. 615-625
-
-
Simpson, A.J.1
Caballero, O.L.2
Jungbluth, A.3
Chen, Y.T.4
Old, L.J.5
-
37
-
-
4644324025
-
Cancer immunotherapy: moving beyond current vaccines
-
Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004; 10: 909-15.
-
(2004)
Nat Med
, vol.10
, pp. 909-915
-
-
Rosenberg, S.A.1
Yang, J.C.2
Restifo, N.P.3
-
38
-
-
78650348177
-
Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination
-
Noguchi M, Mine T, Komatsu N et al. Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination. Cancer Biol Ther 2011; 10: 1266-79.
-
(2011)
Cancer Biol Ther
, vol.10
, pp. 1266-1279
-
-
Noguchi, M.1
Mine, T.2
Komatsu, N.3
-
39
-
-
26244445001
-
Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing
-
Strehl B, Seifert U, Kruger E, Heink S, Kuckelkorn U, Kloetzel PM. Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing. Immunol Rev 2005; 207: 19-30.
-
(2005)
Immunol Rev
, vol.207
, pp. 19-30
-
-
Strehl, B.1
Seifert, U.2
Kruger, E.3
Heink, S.4
Kuckelkorn, U.5
Kloetzel, P.M.6
-
40
-
-
0035796461
-
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products
-
Toes RE, Nussbaum AK, Degermann S et al. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med 2001; 194: 1-12.
-
(2001)
J Exp Med
, vol.194
, pp. 1-12
-
-
Toes, R.E.1
Nussbaum, A.K.2
Degermann, S.3
-
41
-
-
0033662405
-
CD4 + T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells
-
Qin Z, Blankenstein T. CD4 + T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity 2000; 12: 677-86.
-
(2000)
Immunity
, vol.12
, pp. 677-686
-
-
Qin, Z.1
Blankenstein, T.2
-
42
-
-
79955998407
-
Heparanase: a universal immunotherapeutic target in human cancers
-
Zhang YF, Tang XD, Gao JH, Fang DC, Yang SM. Heparanase: a universal immunotherapeutic target in human cancers. Drug Discov Today 2011; 16: 412-7.
-
(2011)
Drug Discov Today
, vol.16
, pp. 412-417
-
-
Zhang, Y.F.1
Tang, X.D.2
Gao, J.H.3
Fang, D.C.4
Yang, S.M.5
-
43
-
-
0033804943
-
Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation
-
Vaday GG, Lider O. Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J Leukoc Biol 2000; 67: 149-59.
-
(2000)
J Leukoc Biol
, vol.67
, pp. 149-159
-
-
Vaday, G.G.1
Lider, O.2
-
44
-
-
33646883248
-
Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells
-
Benhamron S, Nechushtan H, Verbovetski I et al. Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells. J Immunol 2006; 176: 6417-24.
-
(2006)
J Immunol
, vol.176
, pp. 6417-6424
-
-
Benhamron, S.1
Nechushtan, H.2
Verbovetski, I.3
-
45
-
-
0033151591
-
The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
-
Vonderheide RH, Hahn WC, Schultze JL, Nadler LM. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 1999; 10: 673-9.
-
(1999)
Immunity
, vol.10
, pp. 673-679
-
-
Vonderheide, R.H.1
Hahn, W.C.2
Schultze, J.L.3
Nadler, L.M.4
|